Skip to main
BGMS
BGMS logo

BGMS Earnings Dates & Reports

BGMS Most Recent Earnings

Report DateApr 2, 2025
Period EndingQ4 2024
Est. EPS-$4.35
Actual EPS-$4.95
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BGMS Earnings per Share (EPS) History

Signup for full access
Browse free

BGMS Latest Earnings

The value each BGMS share was expected to gain vs. the value each share gained.

BGMS reported its most recent earnings on Apr 2, 2025 for Q4 2024, posting earnings per share (EPS) of -$4.95. This exceeded analysts' expectations of -$4.35 by 13.79%, marking a Miss.

For comparison, Cyclacel Pharmaceuticals Inc reported EPS of -$93.45 in the same quarter last year.

The company is expected to announce its next earnings report on 04/01/2026, with analysts projecting an EPS of -$4.35.

BGMS Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Apr 1, 2026
Next earnings call Apr. 1, 2026
Q3 2025Nov 13, 2025
-$1.31
DeckReportListen
Q2 2025Aug 13, 2025
-$0.98
DeckReportListen
Q1 2025May 15, 2025
-$4.35Next earnings call Apr. 1, 2026
Q4 2024Apr 2, 2025
-$4.35-$4.95+13.79%
DeckReportListen
View all

BGMS Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Cyclacel Pharmaceuticals Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 13, 2025
Aug 13, 2025
May 15, 2025
Apr 2, 2025

BGMS Earnings FAQs

BGMS last reported earnings on Apr 2, 2025 for Q4 2024, posting an EPS of -$4.95, which Miss the estimate of -$4.35 by 13.79%.

For Q4 2024, BGMS reported an EPS of -$4.95, missing analysts' estimate of -$4.35 by 13.79%.

For Q4 2024, BGMS Miss expectations with an actual EPS of -$4.95 vs. an estimated EPS of -$4.35.

Following the last earnings report on Apr 2, 2025, BGMS's stock price moved — from — to —.

The next BGMS earnings call is scheduled for Apr. 1, 2026, where executives will discuss financial results and outlook.

Cyclacel Pharmaceuticals Inc (BGMS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.